Proportion of cancer patients who correctly describe how immunotherapy works (“activates the immune system to kill cancer cells”). CareAcross, a platform providing education for cancer patients, conducted the survey among 5,589 members, primarily in the United Kingdom and Europe. About half of the respondents, who were diagnosed with breast, lung, prostate or colorectal cancer, answered “not sure/do not know.” Said study author Paris Kosmidis, MD, “It is essential for these individuals to be well informed because [immunotherapy] is a complex treatment that is too often mistaken for a miracle cure—and the more they know about it, the better the communication with their medical team and thus the better their outcomes are likely to be.” The study was reported at the 2021 ESMO Congress 2021